Zelboraf Tablet 240mg
Product details
Registration number: SIN14308P
Classification: Prescription Only
Active ingredients: Vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib
Strength: 240mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: ROCHE SINGAPORE PTE. LTD.
ATC code: L01XE15
HSA approval date: 4 February 2013
Manufacturer(s): Delpharm Milano S.r.l.
Manufacturing country/countries: ITALY
What are the HSA registration number and classification for Zelboraf Tablet 240mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14308P
Classification: Prescription Only
What active ingredients and strength are recorded for Zelboraf Tablet 240mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib
Strength: 240mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Zelboraf Tablet 240mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for Zelboraf Tablet 240mg?
According to the HSA dataset updated 7 August 2026:
Registrant: ROCHE SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Zelboraf Tablet 240mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Delpharm Milano S.r.l.
Manufacturing country/countries: ITALY
Where can I look up Zelboraf Tablet 240mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14308P or the exact product name Zelboraf Tablet 240mg. The general register link does not preselect this product.
What are the source dates for this Zelboraf Tablet 240mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Zelboraf Tablet 240mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14308P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)